Singapore reports 151 new HIV cases in 2024, over half diagnosed at late stage
Singapore reported 151 new human immunodeficiency virus (HIV) cases in 2024, with 78 of them diagnosed at a late stage of infection, according to the latest data released by the Communicable Diseases Agency (CDA).
About 62 per cent of the newly reported cases were detected during medical care, with the majority already in the late stage of HIV infection.
The fact that more than half of the new cases were diagnosed late is a cause for concern, Wong Chen Seong, head of the national programs for HIV, hepatitis C, and sexually transmitted infections under the CDA, told local media.
He said that although both early- and late-stage patients can typically suppress the HIV viral load to undetectable levels after three to six months of treatment, those diagnosed at a late stage often already suffer from serious complications due to weakened immune systems.
Treatment for late-stage patients involves not only suppressing the virus to prevent further immune damage, but also managing these concurrent illnesses, Xinhua news agency reported.
He added that once the immune system has been compromised, it can take longer to recover, with the duration varying depending on the patient's overall health, age, and baseline immune status. During this recovery period, individuals are also more vulnerable to other infections.
As of end-2024, a total of 7,137 Singapore residents were known to be living with HIV.
The annual number of new HIV cases in Singapore has been gradually declining over the years, from 300 to 500 cases annually between 2009 and 2019, to around 200 to 250 cases between 2020 and 2023.
According to the World Health Organisation, HIV is a virus that attacks the body's immune system. Acquired immunodeficiency syndrome (AIDS) occurs at the most advanced stage of infection.
HIV targets the body's white blood cells, weakening the immune system. This makes it easier to get sick with diseases like tuberculosis, infections, and some cancers.
HIV is spread from the body fluids of an infected person, including blood, breast milk, semen and vaginal fluids. It is not spread by kisses, hugs, or sharing food. It can also spread from a mother to her baby.
HIV can be prevented and treated with antiretroviral therapy (ART). Untreated HIV can progress to AIDS, often after many years.
WHO now defines Advanced HIV Disease (AHD) as a CD4 cell count less than 200 cells/mm3 or WHO stage 3 or 4 in adults and adolescents. All children younger than 5 years of age living with HIV are considered to have advanced HIV disease.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
Sir Ronald Ross and the mosquito link: how one nobel winning discovery changed the course of malaria control
Before Sir Ronald Ross's discovery in 1897, malaria was understood to be a disease caused by bad air ('mal aria,' meaning bad air). While the disease was recognised and feared for centuries, the underlying cause was not known. Understanding how malaria spreads: A scientific turning point On August 20, 1897, while working in Secunderabad, India, Ross dissected a mosquito that had fed on a malaria-infected patient. Inside its gut lining, he observed the presence of Plasmodium parasites—the microscopic organisms responsible for malaria. This observation provided the medical community with the first solid evidence that mosquitoes act as carriers of the disease. Although French military doctor Charles Laveran had identified Plasmodium in human blood in 1880, the method of transmission remained unclear. Ross, building on the ideas of physician Patrick Manson, confirmed that the malaria parasite requires a mosquito host to complete part of its life cycle before being passed to humans. Marking this discovery, Ross noted in his journal: 'This day relenting God Hath placed within my hand, A wondrous thing…' These words captured not only a breakthrough in understanding infectious disease but also a shift in how malaria prevention would be approached from then on. A scientific method grounded in observation and precision Ross conducted careful experiments using birds infected with Plasmodium relictum, an avian form of malaria. He allowed mosquitoes to feed on these birds and later dissected them at regular intervals. Over time, he found the parasites developing in the mosquito's stomach lining -- later forming what we now know as oocysts. This work revealed the external (or 'extrinsic') development of Plasmodium in the mosquito. Ross had traced the full transmission cycle, proving mosquitoes were not just incidental but a necessary host for the parasite. His work became the foundation of what we now call vector biology—the study of how insects and other organisms transmit diseases. The World Health Organization (WHO) acknowledges Ross's discovery as a pivotal moment in public health, reporting that it 'opened up a new vista for prevention and control of malaria' Changing how public health systems responded to malaria Ross's findings had a direct impact on how malaria was managed in India, Africa, and Southeast Asia. Once mosquitoes were identified as vectors, public health teams focused on controlling mosquito breeding: draining stagnant water, managing swamps, and later using insecticides like DDT. Ross went on to work in Sierra Leone and Mauritius, where he applied these principles in real-world malaria control efforts. He used mapping, statistics, and population data to track infection spread—techniques that are still used in disease surveillance today. In 1902, Ross received the Nobel Prize in Physiology or Medicine for his work. The citation read:'for his work on malaria, by which he has shown how it enters the organism and thereby has laid the foundation for successful research on this disease and methods of combating it.' His legacy Ross was also a prolific writer, poet, and advocate for medical education in the colonies. He pushed for more locally-run laboratories and for training Indian personnel in research methods, long before it became common practice. He also developed early mathematical models for how malaria spreads, laying the groundwork for what would become the Ross-Macdonald model—a widely used formula to estimate malaria transmission based on mosquito and human populations. The Centers for Disease Control and Prevention (CDC) notes that Ross's work, in collaboration with George Macdonald, led to the development of a mathematical model of mosquito-borne pathogen transmission . Over 125 years later, Ross's discovery continues to influence how we fight malaria. Vector control—like bed nets, mosquito repellents, and larvicide treatments—remains one of the most effective strategies to prevent the diseas .The WHO emphasises that controlling insect vectors has played an increasingly important role in reducing the burden of malaria since Ross's discovery . August 20 is now remembered as 'Mosquito Day' in his honor, especially in India. His field lab in Secunderabad has been turned into a memorial, and medical researchers still refer to his original drawings and writings. Sir Ronald Ross died in 1932. At the Liverpool School of Tropical Medicine, where he later taught, his epitaph reads: 'He gave to mankind an immense weapon against death.'
Indian Express
6 hours ago
- Indian Express
Blanket ban on blood donation by trans people, sex workers: Ensuring blood safety is non-negotiable. But stigmatising policies is the wrong way to ensure it
'Imagine you are a transgender person battling dengue fever and urgently need a blood transfusion. Naturally, you turn to your friends and chosen family, many of whom are also transgender. Now, here's the shocking part: They are legally barred from donating blood.' When I said this at a recent dengue conference, the hall fell silent. The audience stared in disbelief. Unfortunately, it is true: In India, under the guidelines issued by the National Blood Transfusion Council (NBTC), transgender individuals, along with men who have sex with men (MSM) and female sex workers, are permanently deferred from donating blood. The reason cited? A supposedly higher risk of transmitting infections such as HIV, Hepatitis B, and Hepatitis C. While 'MSM' and 'female sex workers' are behavioural categories, transgender is a gender identity. It does not inherently indicate high-risk sexual behaviour. Yes, a portion of transgender individuals may engage in sex work — often due to systemic marginalisation — but labelling the entire community as 'high-risk' is not only inaccurate, it's discriminatory. No one wants to contract a life-threatening illness like HIV from a blood transfusion. Ensuring blood safety is non-negotiable. However, safety should be ensured through individual risk assessments, not blanket bans that profile entire communities. This kind of policy plays into the dangerous trope of transgender people as 'AIDS spreaders' — a harmful stereotype rooted in stigma, not science. The transgender community has long been marginalised and was disproportionately impacted by the HIV/AIDS crisis, fighting both a public health emergency and relentless discrimination. While these prohibitory guidelines against trans and MSM groups were adopted by many countries when HIV hit in the '80s, they have been updated with time and new evidence to ensure that safe blood is delivered without senseless stigmatisation. In the UK, these guidelines were revised in 2021; in Canada, in 2022. The US FDA came up with its revised guidelines in 2023, which include a new inclusive screening process that expands blood donor eligibility and eliminates questions based on sexual orientation. The new gender-neutral guidelines have abolished deferral of blood donation from MSM and other communities based on their sexual orientation or gender identity. They now use individual risk-based questions to identify the potential donors with a higher risk of HIV transmission. In contrast, India's NBTC guidelines were last updated in 2017 and still uphold these outdated exclusions. Not only does this perpetuate stigma, but it also ignores the current, medically informed view of HIV transmission. The revised US guidelines highlight important concerns. For example, people on Pre-Exposure Prophylaxis (PrEP) or Post-Exposure Prophylaxis (PEP) may have undetectable levels of HIV in their blood but could still transmit the virus. Similarly, those on antiretroviral therapy (ART) may have suppressed viral loads but are not risk-free donors. These nuances demand in-depth donor histories, not judgemental community-wide bans. Stigmatising policies force people into silence. Individuals from banned communities may feel compelled to lie about their identity to save a loved one's life. That alone is an indictment of the policy's failure. These guidelines have been challenged in the Supreme Court by Nupi Maanbi, a transgender woman, and Santa Khurai from Manipur. Khurai has argued that these guidelines are arbitrary, discriminatory, and unscientific. But the government's lack of seriousness is evident. The case, filed in 2021, languished for years because no lawyer was appointed to represent the government. This apathy on the part of the government, the Ministry of Health and Family Welfare, the National Blood Transfusion Council, and the National AIDS Control Organisation is furthering stigmatisation of marginalised communities while missing out on creating updated guidelines that would allow for more blood donations in India. The Supreme Court has taken a stern view of the matter and asked, 'Are we branding all transgender persons as high-risk? Are we then indirectly stigmatising these communities?' The hypocrisy of labelling an entire community as high risk in the name of 'public safety' was questioned by the Court when it stated, referring to normal vs high risk groups, 'Even so-called 'normal' individuals engage in high-risk behaviour. Why single out entire communities?' It is important to understand that these guidelines are not just about blood donation but about our societal perceptions of a community. Large sections of the medical community have long viewed transgender people as abnormal, mentally ill, perverted, and/or criminal. The transgender community has poor access to healthcare thanks to the systemic barriers of our infrastructure, policies, training, and, most importantly, provider mindsets. However, post the NALSA vs Union of India (2014) judgment, which recognised transgender people and Transgender Persons Act, 2019, there is no room for discrimination against trans people — medically or otherwise. These words by the Supreme Court in the case should guide us: 'Aren't we creating a segregated group? This only deepens stigma, biases, and societal prejudices.' India faces a massive shortfall of blood. An estimated one million units are needed annually to meet the demand. In this context, excluding willing, healthy donors based on outdated, unscientific reasons defies logic and lacks compassion. June 14 was World Blood Donor Day. On this occasion, let's ask our government to revise blood donation guidelines in a way that they are scientific, updated, and aligned with global guidelines without unnecessarily excluding any group of donors or further stigmatising them. After all, blood donation should save lives, not exclude some people or add to the stigma around a few communities. The writer is professor, community medicine, Department of Community Medicine, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard
Hans India
6 hours ago
- Hans India
Condoms and STIs: What they do—and don't protect you from
Condoms are often hailed as the go-to protection against sexually transmitted infections (STIs) and sexually transmitted diseases (STDs). But let's get real: while condoms do reduce your risk, they're not a flawless shield. So yes — it's possible to use a condom correctly and still contract or transmit an STI. Let's break down why that happens, how to reduce your risks, and what to do if you suspect exposure. STI vs. STD — What's the Difference? The terms are often used interchangeably, but technically: STI: Infection present, symptoms may not be. STD: Infection has progressed, and symptoms are visible. Since most sexually transmitted conditions don't cause symptoms (about 66% go unnoticed), many health professionals now prefer 'STI' to describe the broader picture. What Kind of Condoms Are We Talking About? There are two types: External condoms (worn on a penis or dildo) Internal condoms (inserted in the vagina or anus) This guide focuses on external condoms made from latex, polyurethane, or polyisoprene — materials that can help prevent STI transmission. Lambskin condoms? Not on this list. Their porous structure can let viruses through. How Can STIs Still Get Through a Condom? Dr. Felice Gersh, OB-GYN and author of PCOS SOS, says it comes down to two things: 1. Condom Effectiveness Perfect use: 98% effective Typical use: ~85% effective Mistakes like late application, tearing, or improper removal lower that number. 2. STI Transmission Methods STIs spread through: Skin-to-skin contact (HPV, herpes, syphilis, trichomoniasis, molluscum contagiosum) Bodily fluids (HIV, chlamydia, gonorrhea, hepatitis B) Condoms do a great job blocking fluids, but not all skin is covered during sex. Herpes on the scrotum, for example, could still make contact with a partner's skin. Even invisible infections can spread. Just because someone looks STI-free doesn't mean they are. How to Maximize Condom Protection Find the right fit – Not too tight, not too loose. Store correctly – Cool, dry places only (skip the wallet). Check expiry dates – Yes, they matter. Open with fingers – Not teeth! Tears invite trouble. Apply early – Before any genital contact. Put it on correctly – If it's inside-out, toss and start fresh. Leave space at the tip – For ejaculate and to prevent breakage. Remove immediately after ejaculation – Tie it off, trash it (don't flush!). What Else Can You Do to Stay Safe? 1. Know Your STI Status Get tested regularly — at least once a year or before starting a new sexual relationship. Include tests for anal and oral STIs if applicable. 2. Know the Limits of Testing No routine herpes testing without visible symptoms. No HPV tests available for people assigned male at birth. Ask partners about their testing history and symptoms. For example: 'Have you ever had cold sores or been with someone who did?' 'Have any of your past partners had HPV or abnormal Pap smears?' 3. Communicate with Your Partner(s) Bring up your STI history as you ask about theirs. Try: 'I got tested last [month]. Want to get tested together before we go further?' 'Just so you know, my last test was in [month] and I've had [X] partners since. How about you?' Knowledge is power — and consent. When Should You Get Tested After Potential Exposure? Not right away. All STIs have an incubation period (time before they show up on tests): 1–4 weeks: Chlamydia, gonorrhea, trichomoniasis 2 weeks–6 months: Herpes, HIV, syphilis Best approach? Test two weeks after exposure, then again after a few months for accurate results. Tested Positive? Here's What to Do Follow your healthcare provider's advice: Curable STIs like chlamydia and gonorrhea? You'll get antibiotics. Manageable STIs like HIV or herpes? Treatment plans will be tailored for you. Abstain from sex as directed, and notify any recent partners so they can get tested, too. Not sure what to say? Try: 'I just found out I have [X] and wanted to let you know so you can get tested too.' 'I tested positive for [X]. My doctor said it's possible even with condoms, so you might want to check your status.' Keep it kind, simple, and judgment-free. The Bottom Line Condoms are a smart, effective tool for reducing STI risk — but they aren't magic. Using them correctly, knowing your status, and having open conversations with partners go a long way in protecting everyone involved. Safe sex isn't just about latex — it's about communication, education, and a little preparation. And hey, nothing says 'I care' like a well-timed 'when was your last STI test?'
